110 related articles for article (PubMed ID: 9225162)
1. Constitutive and regulated expression of vitronectin.
Seiffert D
Histol Histopathol; 1997 Jul; 12(3):787-97. PubMed ID: 9225162
[TBL] [Abstract][Full Text] [Related]
2. Distribution of vitronectin mRNA during murine development.
Seiffert D; Iruela-Arispe ML; Sage EH; Loskutoff DJ
Dev Dyn; 1995 May; 203(1):71-9. PubMed ID: 7544171
[TBL] [Abstract][Full Text] [Related]
3. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18).
Kanse SM; Matz RL; Preissner KT; Peter K
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2251-6. PubMed ID: 15458976
[TBL] [Abstract][Full Text] [Related]
4. Vitronectin gene expression in the adult human retina.
Anderson DH; Hageman GS; Mullins RF; Neitz M; Neitz J; Ozaki S; Preissner KT; Johnson LV
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3305-15. PubMed ID: 10586957
[TBL] [Abstract][Full Text] [Related]
5. Vitronectin in the cirrhotic liver: an immunomarker of mature fibrosis.
Koukoulis GK; Shen J; Virtanen I; Gould VE
Hum Pathol; 2001 Dec; 32(12):1356-62. PubMed ID: 11774169
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.
Hapke S; Kessler H; Luber B; Benge A; Hutzler P; Höfler H; Schmitt M; Reuning U
Biol Chem; 2003 Jul; 384(7):1073-83. PubMed ID: 12956424
[TBL] [Abstract][Full Text] [Related]
7. Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration.
Sano K; Asanuma-Date K; Arisaka F; Hattori S; Ogawa H
Glycobiology; 2007 Jul; 17(7):784-94. PubMed ID: 17369286
[TBL] [Abstract][Full Text] [Related]
8. Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules.
Seiffert D; Schleef RR
Blood; 1996 Jul; 88(2):552-60. PubMed ID: 8695803
[TBL] [Abstract][Full Text] [Related]
9. Expression of vitronectin and its integrin receptors in the synovial membrane-like interface tissue from aseptic loosening of total hip replacement.
Li TF; Xu JW; Santavirta S; Takagi M; Virtanen I; Pirilä L; Konttinen YT
J Rheumatol; 2000 Mar; 27(3):727-34. PubMed ID: 10743817
[TBL] [Abstract][Full Text] [Related]
10. Vitronectin adsorption on surfaces visualized by tapping mode atomic force microscopy.
Zhang H; Bremmell K; Kumar S; Smart RS
J Biomed Mater Res A; 2004 Mar; 68(3):479-88. PubMed ID: 14762927
[TBL] [Abstract][Full Text] [Related]
11. Vitronectin--master controller or micromanager?
Leavesley DI; Kashyap AS; Croll T; Sivaramakrishnan M; Shokoohmand A; Hollier BG; Upton Z
IUBMB Life; 2013 Oct; 65(10):807-18. PubMed ID: 24030926
[TBL] [Abstract][Full Text] [Related]
12. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
[TBL] [Abstract][Full Text] [Related]
13. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion.
Singh B; Su YC; Riesbeck K
Mol Microbiol; 2010 Nov; 78(3):545-60. PubMed ID: 20807208
[TBL] [Abstract][Full Text] [Related]
14. Increased expression levels of vitronectin in the maternal‑fetal interface of placenta in early-onset severe preeclampsia.
Shen J; Ma X; Yi F; Rasul A; Cui M; Ma T
Mol Med Rep; 2013 Jan; 7(1):53-8. PubMed ID: 23124223
[TBL] [Abstract][Full Text] [Related]
15. Expression, production, and characterization of full-length vitronectin in Escherichia coli.
Wojciechowski K; Chang CH; Hocking DC
Protein Expr Purif; 2004 Jul; 36(1):131-8. PubMed ID: 15177294
[TBL] [Abstract][Full Text] [Related]
16. Characterization of goat plasma vitronectin.
Suchitra S; Ashok V; Gupta T; Joshi P
Indian J Biochem Biophys; 2003 Jun; 40(3):186-93. PubMed ID: 22900309
[TBL] [Abstract][Full Text] [Related]
17. Goat vitronectin: characterization and binding to Staphylococcus aureus.
Mahawar M; Joshi P
Comp Biochem Physiol B Biochem Mol Biol; 2008 Mar; 149(3):410-8. PubMed ID: 18055240
[TBL] [Abstract][Full Text] [Related]
18. Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo.
Seiffert D; Loskutoff DJ
J Biol Chem; 1996 Nov; 271(47):29644-51. PubMed ID: 8939896
[TBL] [Abstract][Full Text] [Related]
19. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation.
Ainscough SL; Barnard Z; Upton Z; Harkin DG
Exp Eye Res; 2006 Dec; 83(6):1505-14. PubMed ID: 17046752
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a specific interaction of vitronectin with arginine: effects of reducing agents on the expression of functional domains and immunoepitopes.
Seiffert D; Wagner NV
Biochimie; 1997 Apr; 79(4):205-10. PubMed ID: 9242985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
